Skip to main content

Advertisement

ADVERTISEMENT

News

News
09/06/2018
More valsartan recalls, prompted by the detection of a carcinogen impurity in an active pharmaceutical ingredient used to manufacture the drug, have been announced announced.
More valsartan recalls, prompted by the detection of a carcinogen impurity in an active pharmaceutical ingredient used to manufacture the drug, have been announced announced.
More valsartan recalls, prompted...
09/06/2018
Pharmacy Learning Network
News
09/06/2018
New recommendations have been released for the 2018-2019 influenza season, according to a new report.
New recommendations have been released for the 2018-2019 influenza season, according to a new report.
New recommendations have been...
09/06/2018
Pharmacy Learning Network

Advertisement

News
09/06/2018
As the EpiPen shortage continues, Walgreens has announced it will supply emergency allergy shots from Kaleo in its stores. 
As the EpiPen shortage continues, Walgreens has announced it will supply emergency allergy shots from Kaleo in its stores. 
As the EpiPen shortage...
09/06/2018
Pharmacy Learning Network
News
09/05/2018
Scott Gottlieb, MD, FDA commissioner, recently explained the steps the FDA is taking to assure that drug products all meet the same high-quality standards, regardless of where they are manufactured.
Scott Gottlieb, MD, FDA commissioner, recently explained the steps the FDA is taking to assure that drug products all meet the same high-quality standards, regardless of where they are manufactured.
Scott Gottlieb, MD, FDA...
09/05/2018
Pharmacy Learning Network
News
09/05/2018
Researchers have discovered thousands of 4- or 5-drug combinations that effectively treat bacteria. 
Researchers have discovered thousands of 4- or 5-drug combinations that effectively treat bacteria. 
Researchers have discovered...
09/05/2018
Pharmacy Learning Network

Advertisement

News
09/04/2018
Researchers examined the use of an opioid—approved to treat moderate to severe pain—for patients with opioid-induced urine retention who do not respond to alpha-1 blockers. 
Researchers examined the use of an opioid—approved to treat moderate to severe pain—for patients with opioid-induced urine retention who do not respond to alpha-1 blockers. 
Researchers examined the use of...
09/04/2018
Pharmacy Learning Network
News
09/04/2018
Over the past six years, several US chain pharmacies have been caught numerous times by the FDA selling tobacco products to minors, a new study finds.
Over the past six years, several US chain pharmacies have been caught numerous times by the FDA selling tobacco products to minors, a new study finds.
Over the past six years, several...
09/04/2018
Pharmacy Learning Network
News
08/30/2018
Michael Menchine, MD, discusses his recent study that examined opioid prescribing rates following the death of a patient and explains why the pen might be mightier than the pill.
Michael Menchine, MD, discusses his recent study that examined opioid prescribing rates following the death of a patient and explains why the pen might be mightier than the pill.
Michael Menchine, MD, discusses...
08/30/2018
Pharmacy Learning Network

Advertisement

News
08/30/2018
The FDA has approved a long-acting treatment for hemophilia A. 
The FDA has approved a long-acting treatment for hemophilia A. 
The FDA has approved...
08/30/2018
Pharmacy Learning Network
News
08/30/2018
The FDA recently said that a serious genital infection has been reported in patients with diabetes taking certain medications. 
The FDA recently said that a serious genital infection has been reported in patients with diabetes taking certain medications. 
The FDA recently said that a...
08/30/2018
Pharmacy Learning Network